We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma (DSM XIII)

This study is currently recruiting participants.
Verified September 2017 by Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Sponsor:
ClinicalTrials.gov Identifier:
NCT01090089
First Posted: March 19, 2010
Last Update Posted: September 8, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
ClinAssess GmbH
Information provided by (Responsible Party):
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2020
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)